The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $2.81

Today's change+0.06 +2.18%
Updated February 12 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $2.81

Today's change+0.06 +2.18%
Updated February 12 4:00 PM -5GMT. Delayed by at least 15 minutes.

Applied DNA Sciences Inc up sharply

Applied DNA Sciences Inc closed up sharply Friday, rallying (U.S.)$0.06 or 2.18% to (U.S.)$2.81. Over the last five days, shares have lost 6.95% and are down 13.27% for the last year to date. This security has underperformed the S&P 500 by 6.64% during the last year.

Key company metrics

  • Open(U.S.) $2.77
  • Previous close(U.S.) $2.75
  • High(U.S.) $2.89
  • Low(U.S.) $2.77
  • Bid / Ask-- / --
  • YTD % change-13.27%
  • Volume84,566
  • Average volume (10-day)80,886
  • Average volume (1-month)118,106
  • Average volume (3-month)603,628
  • 52-week range(U.S.) $2.27 to (U.S.) $9.70
  • Beta0.86
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.34
Updated February 12 4:00 PM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-76.77%

Applied DNA Sciences Inc has a net profit margin of -76.77%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue4221
Total other revenue--------
Total revenue4221
Gross profit--------
Total cost of revenue--------
Total operating expense4435
Selling / general / administrative4435
Research & development1000
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income0-2-2-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax0-2-2-8
Income after tax0-2-2-8
Income tax, total000--
Net income0-2-2-8
Total adjustments to net income--------
Net income before extra. items0-2-2-8
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0-2-2-8
Inc. avail. to common incl. extra. items0-2-2-8
Diluted net income0-2-2-8
Dilution adjustment------0
Diluted weighted average shares22211715
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.08-0.11-0.51
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.02-0.08-0.11-0.51